LC
VKTX icon

Lindbrook Capital’s Viking Therapeutics VKTX Stock Holding History

Lindbrook Capital’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$93.9K Buy
3,888
+3,430
+749% +$108K 0.01% 707
2024
Q4 		$18.4K Sell
458
-88
-16% -$5.02K ﹤0.01% 1326
2024
Q3 		$34.6K Buy
546
+281
+106% +$16.5K ﹤0.01% 997
2024
Q2 		$14K Sell
265
-88
-25% -$5.77K ﹤0.01% 1440
2024
Q1 		$28.9K Buy
353
+278
+371% +$12.4K ﹤0.01% 1028
2023
Q4 		$1.4K Sell
75
-150
-67% -$1.96K ﹤0.01% 2384
2023
Q3 		$2.49K Buy
225
+52
+30% +$744 ﹤0.01% 2047
2023
Q2 		$2.8K Hold
173
– – ﹤0.01% 2025
2023
Q1 		$2.88K Buy
+173
New +$1.79K ﹤0.01% 2090
2022
Q1 		– Sell
-7,500
Closed -$35K – 2624
2021
Q4 		$35K Buy
7,500
+6,855
+1,063% +$38.4K 0.01% 840
2021
Q3 		$4K Hold
645
– – ﹤0.01% 1356
2021
Q2 		$4K Hold
645
– – ﹤0.01% 1408
2021
Q1 		$4K Sell
645
-164
-20% -$1.15K ﹤0.01% 1362
2020
Q4 		$5K Buy
809
+164
+25% +$993 ﹤0.01% 1214
2020
Q3 		$4K Hold
645
– – ﹤0.01% 1217
2020
Q2 		$5K Hold
645
– – ﹤0.01% 1107
2020
Q1 		$3K Hold
645
– – ﹤0.01% 1231
2019
Q4 		$5K Hold
645
– – ﹤0.01% 1121
2019
Q3 		$4K Buy
+645
New +$4.79K ﹤0.01% 1129
2019
Q2 		– Sell
-1,400
Closed -$13K – 1518
2019
Q1 		$13K Sell
1,400
-3,400
-71% -$28.5K 0.01% 828
2018
Q4 		$36K Buy
+4,800
New +$57.4K 0.02% 446

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Lindbrook Capital's VKTX Position: Q1 2025 in Review

Lindbrook Capital increased its Viking Therapeutics (VKTX) stake by 749% in Q1 2025, buying an estimated $108K and bringing the position to 3,888 shares worth $93.9K. The position accounts for 0.01% of the portfolio, ranked #707.

Lindbrook Capital first reported a position in VKTX in Q4 2018 and has held it in 21 quarters since. 372 funds tracked by Wall St. Rank hold VKTX as of Q1 2025.

  • Lindbrook Capital held 3,888 shares of Viking Therapeutics worth $93.9K as of Q1 2025.
  • Lindbrook Capital bought 3,430 Viking Therapeutics shares in Q1 2025, an estimated $108K.
  • Viking Therapeutics made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #707 holding.
  • Lindbrook Capital first reported a position in Viking Therapeutics in Q4 2018 and has held it in 21 quarters since.
  • 372 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.